Efficacy and Safety of Fruquintinib Plus PD-1 Inhibitors Versus Regorafenib Plus PD-1 Inhibitors in Refractory Microsatellite Stable Metastatic Colorectal CancerLi‐Ying Sun, Jianbing Wu|Frontiers in Oncology|2021Cited by 39